- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01617304
Effects of Food Cooking on Diabetes-2 Risk Factors (Age-2)
January 8, 2013 updated by: AAstrup, University of Copenhagen
The aim of the project is to investigate the effects of advanced glycation end products (AGEs) formed in food during the cooking process as well as AGEs formed naturally in the human body, on insulin sensitivity and risk factors for type 2 diabetes.
The hypothesis is that i) food content of AGEs is lower using boiling and steaming cooking methods and that ii) AGEs formation in the body is lower at low dietary intake of certain sugar forms.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederiksberg, Denmark
- Department of Human Nutrition, University of Copenhagen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women, healthy between 20 and 50 y
- BMI between 25 and 40 kg/m2
- weight circumference over 88 cm
Exclusion Criteria:
- weigh changes within the last 2 months more than +/- 3 kg
- Physical activity more than 8 h per week
- smoking
- medications and supplements
- being vegetarian or vegan
- pregnancy or breast feeding
- postmenopause
- chronic disease
- previous gastric bypass surgery
- blood donation within the last 3 months
- Involvement in other clinical trials
- allergic to paraaminobenzoic acid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: low AGE, glucose
Food prepared by boiling/steaming and 20 g of glucose 3 times a day in a water solution
|
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
|
|
Experimental: low AGE, fructose
Food prepared by boiling/steaming and 20 g of fructose 3 times a day in a water solution
|
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
|
|
Experimental: high AGE, fructose
Food prepared by frying/baking and 20 g of fructose 3 times a day in a water solution
|
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
|
|
Experimental: high AGE, glucose
Food prepared by frying/baking and 20 g of glucose 3 times a day in a water solution
|
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in HOMA from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
insulin sensitivity
|
0 and 4 weeks
|
|
change in OGTT from baseline to 4 weeks
Time Frame: 0 and 4 weeks at 0 and 120 min
|
insulin sensitivity
|
0 and 4 weeks at 0 and 120 min
|
|
change in appetite hormones (leptin, adiponectin, GLP-1, glukagon, ghrelin) from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
|
|
change in plasma and urin AGEs from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
|
|
change in immune response (CRP, C-peptide, IL-1B, IL-6, VCAM, ICAM, MIF, TNF-a, buffycoat) from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
|
|
change in metabolomics dats from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
|
|
change in AGE levels in skin from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in lipid profile (TG, Chol, LDL, HDL, ox LDL, glycated LDL, fattyacids)from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
|
change in HbA1c from baseline to 4 weeks
Time Frame: 0 and 4 weeks
|
0 and 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Susanne G Bügel, Department of Human Nutrition, University of Copenhagen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
February 22, 2012
First Submitted That Met QC Criteria
June 7, 2012
First Posted (Estimate)
June 12, 2012
Study Record Updates
Last Update Posted (Estimate)
January 10, 2013
Last Update Submitted That Met QC Criteria
January 8, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M201
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Dietary intervention
-
University of ViennaCompletedEndotoxemia | Dietary HabitsAustria
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
University Hospital, Strasbourg, FranceRecruitingDigestive Cancer | UndernourishedFrance
-
Josephine Ford Cancer CenterNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of South CarolinaAcademy of Nutrition and DieteticsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated